Fire-district
Osage Ambulance District
The current listed document is more than 24 months old and may be outdated.
Drugs and doses45
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Cefazolin9
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 194 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | pages 126, 148 |
| Other | peds | 1 g/kg | PO | not captured | standing | pages 126, 148 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 mg | IV/IO | not captured | standing | pages 122, 149 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 122, 149 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 132, 150, 161 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 132, 150, 161 |
| Stridor | peds | 5 mg | NEB | not captured | standing | page 132 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | page 151 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | page 151 |
| Wide-complex tachycardia | adult | 150 mg | IV | not captured | standing | page 151 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 325 mg | PO | not captured | standing | page 152 |
| Other | peds | 50 mg | PO | not captured | standing | page 152 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5 mg | IV/IO | not captured | standing | pages 121, 153 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 121, 153 |
| Organophosphate poisoning | adult | 1–2 mg | IV | not captured | standing | pages 126, 153 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV | not captured | standing | pages 126, 153 |
| Other | peds | 0.02 mg/kg | IV | not captured | standing | page 75 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 8–16 mg/kg | IV/IO | not captured | standing | page 154 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 154 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2000–3000 mg | IV | not captured | standing | pages 144, 147 |
| Trauma / hemorrhage | peds | 50 mg/kg | IV | not captured | standing | pages 144, 147 |
D–F Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Fentanyl, Furosemide9
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25 g | IV/IO | not captured | standing | page 156 |
| Other | peds | 2–4 mL/kg | IV/IO | not captured | standing | page 156 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5–15 mg | IV | not captured | standing | page 157 |
| Seizure | adult | 5–10 mg | IV/IO/IM | not captured | standing | page 157 |
| Seizure | peds | 0.2 mg/kg | PR | not captured | standing | page 157 |
| Seizure | peds | 0.2–0.5 mg | IV/IO/IM | not captured | standing | page 157 |
| Seizure | peds | 1 mg | IV | not captured | standing | page 157 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.25 mg/kg | IV | not captured | standing | page 158 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 25–50 mg | IV/IM | not captured | standing | page 125 |
| Nausea / vomiting | peds | 1.25 mg/kg | IV/IM | not captured | standing | page 125 |
| Other | adult | 50 mg | IV/IM | not captured | standing | page 114 |
| Other | adult | 50 mg | IV/IM | not captured | standing | page 114 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 114 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 114 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 10 mcg/kg | IV/IO | not captured | standing | page 121 |
| Cardiogenic shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 131 |
| Cardiogenic shock | peds | 2–20 mcg/kg | IV/IO | not captured | standing | page 131 |
| Crush injury | adult | 10 mcg/kg | IV/IO | not captured | standing | page 141 |
| Crush injury | peds | 10 mcg/kg | IV/IO | not captured | standing | page 141 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 114 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 114 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 121 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 118, 119 |
| Cardiac arrest | adult | 2–2.5 mg | ET | not captured | standing | page 163 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 118, 119 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 75, 164 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 75, 164 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mcg/kg | IV/IO | not captured | standing | page 121 |
| Mild to moderate pain | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | pages 106, 165 |
| Mild to moderate pain | peds | 1–4 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 106, 165 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 40 mg | IV/IO | not captured | standing | page 166 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 166 |
G–L Glucagon, Haloperidol, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam9
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 mg | IV/IO | not captured | standing | page 118 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–5 mg | IV/IO | not captured | standing | pages 118, 126, 167 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 118, 126, 167 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 118 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 167 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | page 167 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5–10 mg | IM | not captured | standing | page 169 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 185 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | NEB | not captured | standing | pages 114, 161 |
| Other | peds | 0.25–0.5 mg | NEB | not captured | standing | pages 114, 161 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | pages 60, 75, 170 |
| Other | adult | 2–5 mg/kg | IM | not captured | standing | pages 60, 75, 170 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | pages 60, 75, 170 |
| Other | peds | 2–5 mg/kg | IM | not captured | standing | pages 60, 75, 170 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15–30 mg | IV | not captured | standing | page 106 |
| Mild to moderate pain | adult | 30–60 mg | IM | not captured | standing | page 106 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | page 106 |
| Mild to moderate pain | peds | 1 mg/kg | IM | not captured | standing | page 106 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO | not captured | standing | page 172 |
| Other | adult | 20 mg | IV/IO | not captured | standing | page 172 |
| Other | peds | 0.4–1 mg/kg | IV/IO | not captured | standing | page 172 |
| Other | peds | 0.4–1 mg/kg | IV/IO | not captured | standing | page 172 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 119, 174 |
| Cardiac arrest | peds | 1 mg/kg | IV/IO | not captured | standing | pages 119, 174 |
| Other | adult | 1.5 mg/kg | IV | not captured | standing | page 75 |
| Other | adult | 20–40 mg | IO | not captured | standing | page 175 |
| Other | peds | 1.5 mg/kg | IV | not captured | standing | page 75 |
| Wide-complex tachycardia | adult | 0.5–0.75 mg/kg | IV/IO | not captured | standing | page 174 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | page 174 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 2 mg | IV/IO/IM | not captured | standing | page 176 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | page 176 |
| Seizure | adult | 4 mg | IV/IO/IM | not captured | standing | page 176 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 176 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose, Oxytocin10
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 g | IV/IO | not captured | standing | page 177 |
| Other | adult | 1–2 g | IV/IO | not captured | standing | page 177 |
| Other | adult | 1.2–2 g | IV/IO | not captured | standing | page 177 |
| Other | adult | 4–6 g | IV/IO | not captured | standing | page 177 |
| Other | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 177 |
| Other | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 177 |
| Other | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 177 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1–2 mg/kg | IV/IO | not captured | standing | page 178 |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IO | not captured | standing | page 178 |
| Asthma / bronchospasm | peds | 1 mg/kg | IV/IO | not captured | standing | page 178 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IO | not captured | standing | pages 116, 126, 179 |
| Agitation | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 116, 126, 179 |
| Procedural sedation | adult | 2.5–5 mg | IV/IO/IN | not captured | standing | pages 121, 179 |
| Seizure | adult | 2.5–6 mg | IV/IO/IN | not captured | standing | pages 129, 179 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IN | not captured | standing | pages 129, 179 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–10 mg | IV/IO | not captured | standing | page 121 |
| Other | adult | 2–4 mg | IV/IO | not captured | standing | pages 120, 180 |
| Other | peds | 0.1–0.2 mg/kg | IV/IO | not captured | standing | pages 120, 180 |
| Mild to moderate pain | adult | 2–10 mg | IV/IO/IM/SQ | not captured | standing | pages 106, 180 |
| Mild to moderate pain | peds | 0.1–0.2 mg/kg | IV/IO/IM/SQ | not captured | standing | pages 106, 180 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM/IN/SQ/ET | not captured | standing | page 181 |
| Opioid overdose | peds | 2 mg | IV/IO/IM/IN/SQ/ET | not captured | standing | page 181 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4 mg | SL | not captured | standing | pages 120, 133, 182 |
| Other | adult | 1–2 inch | TD | not captured | standing | pages 120, 182 |
| Other | peds | 0.25–0.5 mcg/kg | IV | not captured | standing | page 183 |
| Other | peds | 0.4 mg | SL | not captured | standing | pages 120, 133, 182 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.02–0.2 mcg/kg | IV | not captured | standing | pages 130, 173 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4–8 mg | IV/IM | not captured | standing | page 196 |
| Other | adult | 4–8 mg | not captured | not captured | standing | page 197 |
| Other | peds | 0.15 mg/kg | IV/IM | not captured | standing | page 196 |
| Other | peds | 4 mg | not captured | not captured | standing | page 197 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25–50 g | PO | not captured | standing | page 168 |
| Hypoglycemia | peds | 0.5 g/kg | PO | not captured | standing | page 168 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10–40 unit | IV | not captured | standing | page 186 |
P–R Promethazine, Racemic Epinephrine, Rocuronium3
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 12.5–25 mg | IV/IM | not captured | standing | pages 112, 125, 187 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mL | NEB | not captured | standing | page 188 |
| Other | peds | 0.25–0.75 mL | NEB | not captured | standing | page 188 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 75, 189 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | pages 75, 189 |
S–Z Sodium Bicarbonate, Succinylcholine, Thiamine, Tranexamic Acid, Vecuronium5
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 118, 119, 126, 141, 190 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 118, 119, 126, 141, 190 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV | not captured | standing | pages 75, 191 |
| Other | peds | 2 mg/kg | IV | not captured | standing | pages 75, 191 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IO | not captured | standing | pages 113, 192 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV | not captured | standing | pages 85, 193 |
| Other | peds | 15 mg/kg | IV | not captured | standing | pages 85, 193 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 75, 78, 195 |
| Other | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 75, 78, 195 |
Cite this
Osage Ambulance District, United States EMS Protocol Census. 135 dose entries, effective 2015-12-08.
https://protoquiz.com/census/agencies/osage-ambulance-district/
The census is free and not for sale. Only public agencies are named.